HMGB1 and neoplasm: Sulfonyl HMGB1 has until now been considered as a functionally inert molecule, mainly defined by an absent capacity to generate inflammation, but these new observations implicate sulfonyl HMGB1 in recruiting immunocompetent cells which inhibit cytotoxic cells, thereby impairing their ability to attack and kill the tumor cells.